All the sessions from Transform 2021 are available on-demand now. Watch now. HOUSTON–(BUSINESS WIRE)–July 26, 2021– ImmunoMet Therapeutics, Inc., a clinical stage biotechnology company targeting metabolism to develop novel anti-fibrotic and anti-cancer therapies, today announced that Dr. Revati Shreeniwas has joined the company as Chief Medical Officer. In this role, Dr. Shreeniwas will manage the […]